[1]王瑞民.阿尔茨海默病等痴呆疾病的脑功能影像学研究[J].国际放射医学核医学杂志,2001,25(5):209-212.
 WANG Rui-min.Functional neuroimaging of Alzheimer’s disease and other dementias[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(5):209-212.
点击复制

阿尔茨海默病等痴呆疾病的脑功能影像学研究(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
25
期数:
2001年第5期
页码:
209-212
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
Functional neuroimaging of Alzheimer’s disease and other dementias
作者:
王瑞民
100853 北京, 中国人民解放军总医院核医学科
Author(s):
WANG Rui-min
Department of Nuclear Medicine, The General Hospital of PLA, Beijing, 100853, China
关键词:
阿尔茨海默病痴呆脑功能影像18F-氟代脱氧葡萄糖正电子发射断层显像
Keywords:
Alzheirmer’s diseasedementiasfunctional neuroimaing18F-FDG PET
分类号:
R817.4
摘要:
痴呆类疾病可分为阿尔茨海默病(AD)、皮克病、多发性梗死性痴呆(MID)等类型,它们各具不同的临床特点。神经心理学检查对痴呆的诊断及鉴别诊断起一定作用。AD等痴呆疾病的神经影像学发展越来越迅速,其中18F-FDG PET脑功能显像技术可以早期发现AD患者大脑皮层顶、颞叶等区域葡萄糖代谢率降低,并且左、右半球不对称。18F-FDG PET方法还可以鉴别诊断AD与其他痴呆类疾病。
Abstract:
Dementing illnesses comprise Alzheimer’s disease (AD), Pick’s disease, Multi-infarct dementia (MID) and other neurological disorders. These diseases have different clinical characters respectively. Neuropsychological examinations can help to diagnose and differential diagnose dementias. The development of neuroimaging dementias is more and more rapid. 18F-FDG PET method shows neocortical hypometabolism occurring in the biparietotemporal lobes and left-right asymmetry of AD patients in the early stage . It can also differential diagnose AD from other dementias.

参考文献/References:

[1] Silverman DHS, Small GW, Phelps ME. Clinical value of neuroimaging in the diagnosis of dementia:sensitivity and specificity of regional cerebral metabolic and other parameters for early identification of Alzheimer’s disease[J]. Clin Posit Imag, 1999, 2(3):119-130.
[2] Frey KA, Minoshima S, Kuhl DE, et al. Neurochemical imaging of Alzheimer’s disease and other degenerative dementias[J]. Q J Nucl Med, 1998, 42:166.
[3] Scheltens P, Pasquier F, Weerts JGE, et al. Qualitative assessment of cerebral atrophy on MRI:Inter-and intra-observer reproducibility in dementia and normal aging[J]. Eur Neurol, 1997, 37:95-99.
[4] Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer’s disease using SPECT[J].Neurology, 1998, 50:1563-1571.
[5] Silverman DHS, Chang CY, Cummings JL, et al.Prognostic value of regional brain metabolism in evaluation of dementia:comparison with long-term clinical outcome[J]. J Nucl Med, 1999, 40(Suppl):5.
[6] Duara R, Grady C, Haxby J, et al. Positron emisson tomography in Alzheimer’s disease[J]. Neurology, 1986, 36:879-887.
[7] Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease with PET[J]. J Nucl Med, 1997, 42:85-94.
[8] Duara R, Barker W, Luis CA. Frontotemporal dementia and Azheimer’s disease:differential diagnosis[J].Dement Geriatr Cogn Dis, 1999, 10(Suppl 1):37-42.
[9] De Reuck J, Decoo D, Marchau M, et al. Positron emission tomography in vascular dementia[J]. J Neurol Sci, 1998, 154:1, 55-61.
[10] Garraux G, Salmon E, Degueldre C, et al. Comparson of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia[J]. Neuroimage, 1999, 10(2):149-162.
[11] Tatlidil R, New P, Mayberg H. FDG positron emission tomography in diffuse Lewy body disease:a case report[J]. Clin Nucl Med, 2000, 25(12):1004-1006.

相似文献/References:

[1]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
 Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[2]段小艺,李淼,王黎,等.阿尔茨海默病PET正电子药物应用与研究进展[J].国际放射医学核医学杂志,2014,38(5):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
 Duan Xiao-yi,Li Miao,Wang Li,et al.Application and research progress of PET positron tracers associated with Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
[3]王新艳,管一晖.阿尔茨海默病的影像学诊断进展[J].国际放射医学核医学杂志,2013,37(1):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
 WANG Xin-yan,GUAN Yi-hui.The advancement in Alzheimer disease of imaging diagnosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
[4]孔艳艳,管一晖,吴平.PET分子探针在阿尔茨海默病早期诊断中的研究进展[J].国际放射医学核医学杂志,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
 KONG Yan-yan,GUAN Yi-hui,WU Ping.Novel PET molecular probes for early diagnosis of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
[5]王颖,蔡莉,李彦生,等.11C-PIB PET在不同时期阿尔茨海默病中的研究进展[J].国际放射医学核医学杂志,2013,37(6):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
 WANG Ying,CAI Li,LI Yan-sheng,et al.Application of 11C-PIB PET in different period of the Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
[6]张冰,徐俊,徐运,等.fMRI在阿尔茨海默病、额颞叶痴呆及路易体痴呆中的研究进展[J].国际放射医学核医学杂志,2010,34(5):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
 ZHANG Bing,XU Jun,XU Yun,et al.The study of fMRI in Alzheimer’s disease, frontotemporal dementia and Lewy bodies dementia[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
[7]陈贵兵,吴华,彭添兴.正电子显像剂11C-匹兹堡化合物B的化学合成及其临床应用[J].国际放射医学核医学杂志,2008,32(3):158.
 CHEN Gui-bing,WU Hua,PENG Tian-xing.Chemical synthesis and clinical application of a new positron imaging agent 11C-Pittsburgh compound-B[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):158.
[8]袁瑛,顾兆祥.放射性核素显像在轻度认知功能障碍中的应用价值[J].国际放射医学核医学杂志,2008,32(4):209.
 YUAN Ying,GU Zhao-xiang.Applications of radionuclide imaging in mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):209.
[9]郭喆,张锦明.阿尔茨海默病的放射性分子显像探针研究进展[J].国际放射医学核医学杂志,2006,30(4):199.
 GUO Zhe,ZHANG Jin-ming.Study on radioactive labeling of molecular probes for Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):199.
[10]蔡汉成,尹端沚,张岚,等.早期诊断阿尔茨海默病的PET分子探针[J].国际放射医学核医学杂志,2006,30(4):202.
 CAI Han-cheng,YIN Duan-zhi,ZHANG Lan,et al.PET molecular probes for early detection of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):202.

备注/Memo

备注/Memo:
收稿日期:2000/11/30。
作者简介:王瑞民(1972-),男,北京市人,中国人民解放军总医院核医学科医师,硕士研究生,主要从事神经核医学方面的研究。
更新日期/Last Update: 1900-01-01